144 related articles for article (PubMed ID: 9389360)
41. [MALT-lymphoma--conservative therapy].
Fischbach W
Praxis (Bern 1994); 1996 Nov; 85(45):1455-8. PubMed ID: 8975357
[TBL] [Abstract][Full Text] [Related]
42. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003.
Jezersek Novaković B; Vovk M; Juznic Setina T
Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146
[TBL] [Abstract][Full Text] [Related]
43. Clinical manifestations of primary pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in Japanese population.
Ogusa E; Tomita N; Ishii Y; Takasaki H; Hattori Y; Matsumoto C; Ishigatsubo Y
Hematol Oncol; 2013 Mar; 31(1):18-21. PubMed ID: 22278757
[TBL] [Abstract][Full Text] [Related]
44. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication.
Hong SS; Jung HY; Choi KD; Song HJ; Lee GH; Oh TH; Jo JY; Kim KJ; Byeon JS; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI
Helicobacter; 2006 Dec; 11(6):569-73. PubMed ID: 17083379
[TBL] [Abstract][Full Text] [Related]
45. Bilateral, primary, low-grade, diffuse B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) of the breast.
Zobolas B; Sakorafas GH; Kourakli I; Tsiotou AG
Breast J; 2002; 8(6):382. PubMed ID: 12390362
[No Abstract] [Full Text] [Related]
46. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Chen LT; Lin JT; Shyu RY; Jan CM; Chen CL; Chiang IP; Liu SM; Su IJ; Cheng AL
J Clin Oncol; 2001 Nov; 19(22):4245-51. PubMed ID: 11709568
[TBL] [Abstract][Full Text] [Related]
47. [Gastric MALT lymphoma: anatomo-clinical data and outcome of early stage H. pylori-associated gastric MALT-lymphoma resistant to treatment].
Chelly I; Adouni O; Chouaib S; Azouz H; Nfoussi H; Haouet S; Zitouna M; Kchir N
Tunis Med; 2011 Dec; 89(12):910-5. PubMed ID: 22198892
[TBL] [Abstract][Full Text] [Related]
48. [Primary MALT-type lymphoma of the breast].
Rafel M; Esteve J; Cervantes F; Velasco M; Serra A; Campo E; Montserrat E
Sangre (Barc); 1998 Jun; 43(3):244-7. PubMed ID: 9741235
[TBL] [Abstract][Full Text] [Related]
49. Multimodality Treatment of Gastric Lymphoma.
Ikoma N; Badgwell BD; Mansfield PF
Surg Clin North Am; 2017 Apr; 97(2):405-420. PubMed ID: 28325194
[TBL] [Abstract][Full Text] [Related]
50. An unusual liver mass.
Cabassa P; Morone M; Matricardi L
Gastroenterology; 2010 Feb; 138(2):e7-9. PubMed ID: 20036706
[No Abstract] [Full Text] [Related]
51. Prognostic factors in primary gastric lymphoma.
Medina-Franco H; Germes SS; Maldonado CL
Ann Surg Oncol; 2007 Aug; 14(8):2239-45. PubMed ID: 17546474
[TBL] [Abstract][Full Text] [Related]
52. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression.
Liao Z; Ha CS; McLaughlin P; Manning JT; Hess M; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):399-403. PubMed ID: 10974453
[TBL] [Abstract][Full Text] [Related]
53. Gastric mucosal-associated lymphoid tissue lymphoma.
Fischbach W
Gastroenterol Clin North Am; 2013 Jun; 42(2):371-80. PubMed ID: 23639646
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.
Hammel P; Haioun C; Chaumette MT; Gaulard P; Divine M; Reyes F; Delchier JC
J Clin Oncol; 1995 Oct; 13(10):2524-9. PubMed ID: 7595703
[TBL] [Abstract][Full Text] [Related]
55. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
56. [Primary non-Hodgkin lymphoma of the stomach--internal medicine aspects].
Fischbach W
Praxis (Bern 1994); 1995 Nov; 84(48):1427-31. PubMed ID: 8533004
[TBL] [Abstract][Full Text] [Related]
57. Non-Hodgkin's lymphoma of the paranasal sinuses: clinical and pathological features, and response to combined-modality therapy.
Hausdorff J; Davis E; Long G; Hoppe R; van der Pas M; Lassman C; Kamel O; Jacobs C
Cancer J Sci Am; 1997; 3(5):303-11. PubMed ID: 9327155
[TBL] [Abstract][Full Text] [Related]
58. Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001.
Thieblemont C; Dumontet C; Bouafia F; Hequet O; Arnaud P; Espinouse D; Felman P; Berger F; Salles G; Coiffier B
Leuk Lymphoma; 2003 Feb; 44(2):257-62. PubMed ID: 12688342
[TBL] [Abstract][Full Text] [Related]
59. [Gastric MALT lymphoma and Helicobacter pylori].
Accardo D; Apuzzo M; Bazuro ME; Ferrara M; Tammaro G; Pippa G
Recenti Prog Med; 2000 Apr; 91(4):181-5. PubMed ID: 10804751
[TBL] [Abstract][Full Text] [Related]
60. [Treatment of gastric MALT lymphoma by H. pylori eradication].
Saito D; Ono H; Kouzu T; Gotouda T; Inui T; Oda I
Nihon Rinsho; 2001 Feb; 59(2):355-60. PubMed ID: 11218412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
